At the news
? NEUTRALIMPACT 2/10 6-K filed Jun 15, 2026 at 11:08 ET
Genmab A/S filed its updated Articles of Association via a 6-K on June 15, 2026, reflecting standard corporate governance provisions including share capital details, authorized capital increases, employee warrant programs, and a board indemnification scheme. This is a routine administrative filing with no financial results, material events, or strategic announcements.
- Share capital is DKK 62,353,067 divided into shares of DKK 1 each.
- Board authorized until March 12, 2029 to increase share capital by up to DKK 6,600,000 (with or without pre-emption rights).
- Multiple warrant programs for employees (excluding executive management) with up to DKK 750,000 nominal each, expiring between 2026 and 2030.
- Board authorized to issue convertible debt instruments up to DKK 3,000,000 nominal until March 12, 2029.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access